Search research articles
Contact Us
Filters
Showing results (11-20 of 339) with videos related to
Page
of 34
Sort By:
Frontiers in Oncology
|
March 13, 2025
Editorial: MDS: new scientific and clinical developments
Sabine Blum, Argiris Symeonidis, Ulrich Germing
Frontiers in Oncology
|
December 6, 2021
Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview
Andrea Kuendgen, Annika Kasprzak, Ulrich Germing
Expert Review of Hematology
|
November 19, 2010
Prognostic molecular markers in myelodysplastic syndromes
Judith Neukirchen, Rainer Haas, Ulrich Germing
International Journal of Oncology
|
December 18, 2001
Levels of circulating endothelial adhesion molecules in patients with myelodysplastic syndromes
Thomas Südhoff, Ulrich Germing, Carlo Aul
Blood
|
September 29, 2023
Diagnosis and classification of myelodysplastic syndromes
Robert P Hasserjian, Ulrich Germing, Luca Malcovati
Blood Research
|
January 17, 2017
Mesenchymal stromal cells in myeloid malignancies
Thomas Schroeder, Stefanie Geyh, Ulrich Germing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 7, 2006
Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies
Aristoteles A N Giagounidis, Ulrich Germing, Carlo Aul
Deutsches Arzteblatt International
|
January 31, 2023
Myelodysplastic Syndromes: New Methods of Diagnosis, Prognostication, and Treatment
Kathrin Nachtkamp, Guido Kobbe, Norbert Gattermann, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
November 16, 2002
[Myelodysplastic syndromes. Diagnosis and therapeutic strategies]
Carlo Aul, Aristoteles Giagounidis, Ulrich Germing, et al.
Blood
|
July 19, 2002
New prognostic parameters for chronic myelomonocytic leukemia
Ulrich Germing, Corinna Strupp, Manuel Aivado, et al.
Page
of 34
Search research articles
Search
Showing results (11-20 of 339) with videos related to
Sort By:
Page
of 34
Frontiers in Oncology
|
March 13, 2025
Editorial: MDS: new scientific and clinical developments
Sabine Blum, Argiris Symeonidis, Ulrich Germing
Frontiers in Oncology
|
December 6, 2021
Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview
Andrea Kuendgen, Annika Kasprzak, Ulrich Germing
Expert Review of Hematology
|
November 19, 2010
Prognostic molecular markers in myelodysplastic syndromes
Judith Neukirchen, Rainer Haas, Ulrich Germing
International Journal of Oncology
|
December 18, 2001
Levels of circulating endothelial adhesion molecules in patients with myelodysplastic syndromes
Thomas Südhoff, Ulrich Germing, Carlo Aul
Blood
|
September 29, 2023
Diagnosis and classification of myelodysplastic syndromes
Robert P Hasserjian, Ulrich Germing, Luca Malcovati
Blood Research
|
January 17, 2017
Mesenchymal stromal cells in myeloid malignancies
Thomas Schroeder, Stefanie Geyh, Ulrich Germing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 7, 2006
Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies
Aristoteles A N Giagounidis, Ulrich Germing, Carlo Aul
Deutsches Arzteblatt International
|
January 31, 2023
Myelodysplastic Syndromes: New Methods of Diagnosis, Prognostication, and Treatment
Kathrin Nachtkamp, Guido Kobbe, Norbert Gattermann, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
November 16, 2002
[Myelodysplastic syndromes. Diagnosis and therapeutic strategies]
Carlo Aul, Aristoteles Giagounidis, Ulrich Germing, et al.
Blood
|
July 19, 2002
New prognostic parameters for chronic myelomonocytic leukemia
Ulrich Germing, Corinna Strupp, Manuel Aivado, et al.
Page
of 34